CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-06 | CARDOZA GEORGE President, Pharma Services | Sale | −51,556 | $22.82 | $1.2M | 304,831 |
| 2019-11-06 | CARDOZA GEORGE President, Pharma Services | Exercise or conversion · Stock Option (Right to Buy) | −55,556 | 144,444 | ||
| 2019-11-01 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −35,801 | $22.74 | $814K | 145,640 |
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion | +6,667 | $4.78 | $32K | 34,952 |
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion | +8,333 | $9.11 | $76K | 43,285 |
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion | +6,666 | $7.27 | $48K | 49,951 |
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion | +3,017 | $11.60 | $35K | 52,968 |
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion · Stock Option (Right to Buy) | −6,667 | 0 | ||
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion · Stock Option (Right to Buy) | −8,333 | 0 | ||
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion · Stock Option (Right to Buy) | −6,666 | 3,334 | ||
| 2019-10-31 | Johnson Kevin C Director | Exercise or conversion · Stock Option (Right to Buy) | −3,017 | 0 | ||
| 2019-10-31 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +96,166 | $8.03 | $772K | 251,914 |
| 2019-10-31 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −70,473 | $23.11 | $1.6M | 181,441 |
| 2019-10-31 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −96,166 | 192,334 | ||
| 2019-09-10 | JONES STEVEN C Director | Sale | −1,200 | $21.47 | $26K | 46,457 |
| 2019-09-10 | JONES STEVEN C Director | Gift | −3,400 | 43,057 | ||
| 2019-09-09 | HANNAH ALISON L. Director | Exercise or conversion | +3,333 | $6.66 | $22K | 67,765 |
| 2019-09-09 | HANNAH ALISON L. Director | Exercise or conversion | +8,333 | $9.11 | $76K | 76,098 |
| 2019-09-09 | HANNAH ALISON L. Director | Exercise or conversion · Stock Option (Right to Buy) | −3,333 | $6.66 | $22K | 0 |
| 2019-09-09 | HANNAH ALISON L. Director | Exercise or conversion · Stock Option (Right to Buy) | −8,333 | $9.11 | $76K | 0 |
Page 36 of 51 · 1,005 trades